Carl Zeiss Meditec Dirección
Dirección controles de criterios 4/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Markus Weber
Chief Executive Officer (CEO)
€1.1m
Compensación total
| Porcentaje del salario del CEO | 40.5% |
| Permanencia del CEO | 2.3yrs |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 4.1yrs |
| Promedio de permanencia en la Junta Directiva | 3yrs |
Actualizaciones recientes de la dirección
Here's Why We Think Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation Looks Fair for the time being
May 21
How Should Investors Feel About Carl Zeiss Meditec's (ETR:AFX) CEO Remuneration?
Feb 16
Recent updates
Is There Now An Opportunity In Carl Zeiss Meditec AG (ETR:AFX)?
Mar 24Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?
Mar 11Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement
Feb 12Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
Jan 29What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?
Dec 08Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital
Nov 08Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price
Oct 24Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?
Sep 24Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?
Sep 08Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
Jul 24We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)
Jun 19Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?
Jun 06Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?
May 22Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price
Apr 19Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet
Feb 26Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 10Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching
Jan 28Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10
Jan 12Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10
Dec 29Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10
Dec 14What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?
Nov 04Calculating The Intrinsic Value Of Carl Zeiss Meditec AG (ETR:AFX)
Oct 18Investors Will Want Carl Zeiss Meditec's (ETR:AFX) Growth In ROCE To Persist
Sep 12Carl Zeiss Meditec (ETR:AFX) Seems To Use Debt Rather Sparingly
Aug 25Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Hit The Brakes
May 30Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?
Feb 27Carl Zeiss Meditec's (ETR:AFX) Returns Have Hit A Wall
Feb 08Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching
Dec 12Carl Zeiss Meditec (ETR:AFX) Has Some Way To Go To Become A Multi-Bagger
Nov 06If You Like EPS Growth Then Check Out Carl Zeiss Meditec (ETR:AFX) Before It's Too Late
Sep 06Investors Met With Slowing Returns on Capital At Carl Zeiss Meditec (ETR:AFX)
Aug 08Here's Why We Think Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation Looks Fair for the time being
May 21Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems
May 18Capital Allocation Trends At Carl Zeiss Meditec (ETR:AFX) Aren't Ideal
Apr 28Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 19% Below Its Share Price
Mar 09How Should Investors Feel About Carl Zeiss Meditec's (ETR:AFX) CEO Remuneration?
Feb 16What Type Of Shareholders Own The Most Number of Carl Zeiss Meditec AG (ETR:AFX) Shares?
Jan 30Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | €277m |
| Sep 30 2023 | €1m | €426k | €290m |
| Jun 30 2023 | n/a | n/a | €308m |
| Mar 31 2023 | n/a | n/a | €278m |
| Dec 31 2022 | n/a | n/a | €307m |
| Sep 30 2022 | €1m | €298k | €294m |
Compensación vs. Mercado: La compensación total de Markus($USD1.12M) está por debajo de la media de empresas de tamaño similar en el mercado German ($USD3.54M).
Compensación vs. Ingresos: La compensación de Markus ha sido consistente con los resultados de la empresa en el último año.
CEO
Markus Weber
2.3yrs
Permanencia
€1,050,400
Compensación
Dr. Markus Weber is CEO & Chairman of Management Board of Carl Zeiss Meditec AG from January 01, 2022 and served as its President since January 01, 2022 until December 2022. He joined ZEISS Semiconductor M...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Chairman of Management Board | 2.3yrs | €1.05m | sin datos | |
| CFO & Member of the Management Board | 5.6yrs | €799.30k | sin datos | |
| Head of Global Regulatory & Clinical Affairs | 1.3yrs | sin datos | sin datos | |
| Chief Operating Officer | no data | sin datos | sin datos | |
| Director of Investor Relations | no data | sin datos | sin datos | |
| Chief Human Resources Officer | no data | sin datos | sin datos | |
| Chief Medical Officer for Global Ophthalmic Devices | 7.6yrs | sin datos | sin datos | |
| Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec | 4.2yrs | sin datos | sin datos | |
| President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit | 4yrs | sin datos | sin datos | |
| Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology | no data | sin datos | sin datos |
4.1yrs
Permanencia media
58yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de AFX se considera experimentado (4 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Head of Global Regulatory & Clinical Affairs | 1.2yrs | sin datos | sin datos | |
| Chairman of the Supervisory Board | 3.9yrs | sin datos | sin datos | |
| Honorary Chairman of the Supervisory Board | 3yrs | €43.10k | sin datos | |
| Member of the Supervisory Board | 3.9yrs | €36.00k | sin datos | |
| Member of the Supervisory Board | 3yrs | €55.00k | sin datos | |
| Employee Representative Member of the Supervisory Board | 1.2yrs | sin datos | sin datos | |
| Member of the Supervisory Board | 6.1yrs | €52.00k | sin datos | |
| Employee Representative Deputy Chairman of Supervisory Board | 4.6yrs | €40.50k | sin datos | |
| Employee Representative Member of Supervisory Board | 4.2yrs | €36.00k | sin datos | |
| Member of Supervisory Board | 3yrs | sin datos | sin datos | |
| Employee Representative Member of the Supervisory Board | 2.2yrs | €19.20k | sin datos | |
| Employee Representative Member of the Supervisory Board | 1.2yrs | sin datos | sin datos |
3.0yrs
Permanencia media
52yo
Promedio de edad
Junta con experiencia: La junta directiva de AFX se considera experimentada (3 años de antigüedad promedio).